MS. ELIZABETH SAN LUIS, MSN, PNP
Nursing at Parnassus Ave, San Francisco, CA
License number
California 242420
Category
Nursing
Type
Nurse Practitioner
Address
Address
400 Parnassus Ave, San Francisco, CA 94143
Phone
(415) 353-2111
(415) 353-2680 (Fax)
(415) 476-4029
(415) 476-4150 (Fax)
(415) 353-2680 (Fax)
(415) 476-4029
(415) 476-4150 (Fax)
Personal information
See more information about ELIZABETH SAN LUIS at radaris.comName
Address
Phone
239 N Gower St, Los Angeles, CA 90004
929 Irolo St APT 3, Los Angeles, CA 90006
8420 Boyne St, Downey, CA 90242
3430 Grasswood Dr, El Sobrante, CA 94803
285 Bollenbacher Dr, Salinas, CA 93906
Organization information
See more information about ELIZABETH SAN LUIS at bizstanding.comElizabeth San Luis
400 Parnassus Ave, San Francisco, CA 94143
Categories:
Nurse Practitioners
Phone:
(415) 353-4624 (Phone)
Professional information
See more information about ELIZABETH SAN LUIS at trustoria.com
Pediatric Nurse Practitioner At University Of California, San Francisco
Pediatric Nurse Practitioner At University Of California, San Francisco
Location:
San Francisco Bay Area
Industry:
Hospital & Health Care
Elizabeth San Luis, San Francisco CA - MSN (Master of Science in Nursing)
Elizabeth San Luis, San Francisco CA - MSN (Master of Science in Nursing)
Specialties:
Nursing (Nurse Practitioner)
Address:
400 Parnassus Ave SUITE 625, San Francisco 94143
(415) 353-2111 (Phone), (415) 353-2680 (Fax)
(415) 353-2111 (Phone), (415) 353-2680 (Fax)
Languages:
English
Use Of Leukemia Inhibitory Factor And Endothelin Antagonists
Use Of Leukemia Inhibitory Factor And Endothelin Antagonists
US Patent:
6653287, Nov 25, 2003
Filed:
Sep 13, 2000
Appl. No.:
09/660590
Inventors:
Napoleone Ferrara - San Francisco CA
Kathleen King - Pacifica CA
Elizabeth Luis - San Francisco CA
Jennie P. Mather - Millbrae CA
Nicholas F. Paoni - Belmont CA
Kathleen King - Pacifica CA
Elizabeth Luis - San Francisco CA
Jennie P. Mather - Millbrae CA
Nicholas F. Paoni - Belmont CA
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 3817
US Classification:
514 21, 514 2, 530300, 530350
Abstract:
A leukemia inhibitory factor antagonist, alone or in combination with an endothelin antagonist, may be used for treatment of heart failure. The antagonist(s) are administered in a chronic fashion, in therapeutically effective amounts, to achieve this purpose.
Use Of Leukemia Inhibitory Factor And Endothelin Antagonists
Use Of Leukemia Inhibitory Factor And Endothelin Antagonists
US Patent:
6156733, Dec 5, 2000
Filed:
Feb 13, 1998
Appl. No.:
9/023967
Inventors:
Napoleone Ferrara - San Francisco CA
Kathleen King - Pacifica CA
Elizabeth Luis - San Francisco CA
Jennie P. Mather - Millbrae CA
Nicholas F. Paoni - Belmont CA
Kathleen King - Pacifica CA
Elizabeth Luis - San Francisco CA
Jennie P. Mather - Millbrae CA
Nicholas F. Paoni - Belmont CA
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 3817, C07K 1447, C07K 14705, C07K 14715
US Classification:
514 21
Abstract:
A leukemia inhibitory factor antagonist, alone or in combination with an endothelin antagonist, may be used for treatment of heart failure. The antagonist(s) are administered in a chronic fashion, in therapeutically effective amounts, to achieve this purpose.
Use Of Leukemia Inhibitory Factor Specific Antibodies And Endothelin Antagonists For Treatment Of Cardiac Hypertrophy
Use Of Leukemia Inhibitory Factor Specific Antibodies And Endothelin Antagonists For Treatment Of Cardiac Hypertrophy
US Patent:
5573762, Nov 12, 1996
Filed:
Apr 24, 1995
Appl. No.:
8/428002
Inventors:
Napoleone Ferrara - San Francisco CA
Kathleen King - Pacifica CA
Elizabeth Luis - San Francisco CA
Jennie P. Mather - Millbrae CA
Nicholas F. Paoni - Belmont CA
Kathleen King - Pacifica CA
Elizabeth Luis - San Francisco CA
Jennie P. Mather - Millbrae CA
Nicholas F. Paoni - Belmont CA
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 39395, A61K 3812
US Classification:
4241451
Abstract:
A leukemia inhibitory factor antagonist, alone or in combination with an endothelin antagonist, may be used for treatment of heart failure. The antagonist(s) are administered in a chronic fashion, in therapeutically effective amounts, to achieve this purpose.
Method Of Treating Heart Failure Using Leukemia Inhibitory Factor Antagonists Optionally With Endothelin Antagonists
Method Of Treating Heart Failure Using Leukemia Inhibitory Factor Antagonists Optionally With Endothelin Antagonists
US Patent:
5837241, Nov 17, 1998
Filed:
Jul 26, 1996
Appl. No.:
8/693826
Inventors:
Napoleone Ferrara - San Francisco CA
Kathleen King - Pacifica CA
Elizabeth Luis - San Francisco CA
Jennie P. Mather - Millbrae CA
Nicholas F. Paoni - Belmont CA
Kathleen King - Pacifica CA
Elizabeth Luis - San Francisco CA
Jennie P. Mather - Millbrae CA
Nicholas F. Paoni - Belmont CA
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 39395, C12N 512, C07K 1618, C07K 1622
US Classification:
4241361
Abstract:
A leukemia inhibitory factor antagonist, alone or in combination with an endothelin antagonist, may be used for treatment of heart failure. The antagonist(s) are administered in a chronic fashion, in therapeutically effective amounts, to achieve this purpose.